Publicis: finalises sale of PHS division
(CercleFinance.com) - Publicis group announces the closure of the sale - to Altamont Capital Partners - of its pharmaceutical marketing units collected under the banner of Publicis Health Solutions (PHS), previously owned by the Publicis - health solution division.
This division had been subject to a strategic review by the media group, a review that began in June 2018. The divestment process was initiated in October of the same year, and the sale was signed by the end of 2018.
PHS employs medical and marketing representatives for pharmaceutical, biotechnology, medical devices and diagnostics. It includes brands such as Tuchpoint, PDI, Tardis Medical, PHrequency and CustomPoint Recruiting.
Copyright (c) 2019 CercleFinance.com. All rights reserved.
This division had been subject to a strategic review by the media group, a review that began in June 2018. The divestment process was initiated in October of the same year, and the sale was signed by the end of 2018.
PHS employs medical and marketing representatives for pharmaceutical, biotechnology, medical devices and diagnostics. It includes brands such as Tuchpoint, PDI, Tardis Medical, PHrequency and CustomPoint Recruiting.
Copyright (c) 2019 CercleFinance.com. All rights reserved.